PSUR, PBRER & DSUR Management Across Africa

Is Your Next PSUR Deadline on Track?

Missed PSUR deadlines and poor-quality periodic safety reports are among the most common findings in pharmacovigilance inspections. Jeyflex provides end-to-end Periodic Safety Report management covering PSURs, PBRERs, and DSURs, ensuring your safety reports are accurate, compliant, and submitted on time across every African market you operate in.

What are Periodic Safety Reports?

Periodic Safety Reports are regulatory submissions that compile and evaluate cumulative safety data for a medicinal product over a defined period. They are a core pharmacovigilance obligation — required by regulatory authorities globally and increasingly by African national regulatory authorities — providing a comprehensive benefit-risk assessment of your product throughout its lifecycle.

 

There are three main types of periodic safety reports:

DSUR – Development Safety Update Report: required annually for products in clinical development, covering all ongoing trials
PBRER – Periodic Benefit-Risk Evaluation Report: the ICH E2C(R2) aligned international format accepted by EMA, WHO, and most African NRAs
PSUR – Periodic Safety Update Report: required post-approval, submitted at defined intervals to demonstrate ongoing benefit-risk

Jeyflex manages the full PSUR lifecycle from data collection and analysis through to final submission, so your deadlines are never at risk.

Our Step-by-Step PSUR Management Process

Every periodic safety report is managed through a structured, audit-ready workflow — aligned with ICH E2C(R2), GVP Module VII, and the specific submission requirements of each target regulatory authority.

01

PSUR Planning & Timeline Management

We establish a clear PSUR schedule for your product portfolio — mapping all submission deadlines across each African market and international authority, with built-in timelines for data collection, drafting, review, and final submission.

02

Data Collection & Cumulative Analysis

We compile all cumulative safety data for the reporting period — including ICSRs, literature findings, clinical study data, and regulatory authority communications — and perform a thorough analysis of the overall safety profile.

03

Benefit-Risk Evaluation

Our medical experts perform a rigorous, evidence-based benefit-risk evaluation for the reporting period — assessing whether the product’s benefits continue to outweigh its risks in light of all cumulative safety data collected.

04

Report Authoring & Quality Review

We author the complete PSUR or PBRER in the required format — ICH E2C(R2) structure for international submissions or the specific format required by the target African regulatory authority — followed by a thorough quality review before client sign-off.

05

Regulatory Submission & Follow-Up

We manage the formal submission of your PSUR or PBRER to the relevant regulatory authority within the required deadline — and follow up on any queries or requests for additional information from the authority.

06

Archive & Next Cycle Preparation

The completed report is archived in an inspection-ready format and the next reporting cycle is immediately planned — ensuring continuity, no gaps, and no last-minute deadline pressure in the next period.

PSUR, PBRER and DSUR - What is the Difference?

While these three report types all fall under the periodic safety reporting umbrella, they serve different purposes and are submitted to different audiences at different stages of a product’s lifecycle.

PSUR – submitted post-approval to demonstrate the product’s benefit-risk balance remains positive throughout its licensed lifetime
PBRER – the internationally harmonised ICH E2C(R2) format accepted by EMA, WHO, and most African NRAs as the standard periodic safety reporting format
DSUR – submitted annually for products in clinical development; covers all ongoing trials globally and evaluates the safety profile of the investigational product

Jeyflex manages all three report types — so your entire periodic safety reporting programme is covered under one expert team.

Why Choose Jeyflex for Periodic Safety Report Management?

Deadline Management

We maintain a rigorous submission calendar across your full product portfolio and all African markets — so PSUR and PBRER deadlines are tracked, planned for, and never missed.

Medical Expertise

Our pharmacovigilance professionals and medical reviewers produce rigorous benefit-risk evaluations — not just data summaries — ensuring your PSUR reflects the full clinical picture.

Pan-African Coverage

We manage PSUR submissions across 16 African markets — understanding the specific format, timeline, and submission requirements of each national regulatory authority.

ISO 9001:2015 Certified

Every PSUR produced under our ISO-certified quality management system is subject to documented review processes — ensuring accuracy, consistency, and inspection-readiness at every stage.

Integrated with Your PV System

PSUR data and findings feed directly into signal management, PSMF updates, and RMP revisions — ensuring your full PV system stays aligned after each reporting cycle.

Scalable to Your Portfolio

From a single product to a full portfolio across multiple markets — we scale our PSUR management services to match your exact needs, volume, and regulatory footprint.

Our Periodic Safety Reporting Services

A complete suite of periodic safety reporting services covering every stage of the PSUR, PBRER, and DSUR lifecycle.

PSUR and PBRER authoring in ICH E2C(R2) format
DSUR preparation for products in clinical development
Cumulative safety data compilation and line listing preparation
Benefit-risk evaluation and summary of safety concerns
Signal evaluation for inclusion in PSUR appendices
PSUR schedule planning and submission timeline management
Submission to African NRAs and international regulatory authorities
Response to regulatory authority queries following PSUR submission
PSUR quality review and pre-submission audit
Archive and lifecycle management of submitted PSURs

The Cost of a Missed PSUR Deadline

A missed PSUR deadline is not just a procedural issue — it is a pharmacovigilance compliance failure with direct regulatory consequences:

Regulatory warning letters and formal non-compliance notices
Suspension or revocation of marketing authorisation
Inspection findings directly linked to periodic safety reporting failures
Reputational damage with regulatory authorities affecting future submissions

Timely, accurate PSUR submission is a non-negotiable regulatory obligation, not an optional compliance activity.

Frequently Asked Questions

A PSUR (Periodic Safety Update Report) is the traditional format for periodic safety reporting, while a PBRER (Periodic Benefit-Risk Evaluation Report) is the internationally harmonised format developed under ICH E2C(R2). The PBRER is now accepted by most regulatory authorities globally, including the EMA, WHO, and a growing number of African NRAs, as the standard format for periodic safety submissions. In practice the two terms are often used interchangeably. Jeyflex authors reports in whichever format is required by the specific regulatory authority.

PSUR submission frequency depends on the product’s approval status and the regulatory authority’s requirements. Common intervals are every 6 months for the first two years post-approval, annually for the following three years, and every three years thereafter — though this varies by market and product risk profile. Jeyflex manages your full submission calendar to ensure all deadlines are tracked and met across every African market where your product is registered.

Yes. An increasing number of African national regulatory authorities — including Kenya’s PPB, Uganda’s NDA, Ethiopia’s EFDA, Rwanda’s RFDA, Tanzania’s TMDA, Nigeria’s NAFDAC, and South Africa’s SAHPRA — require periodic safety reports as part of post-marketing pharmacovigilance obligations. Requirements vary by country and product type. Jeyflex advises on the specific PSUR requirements for each target market and manages submissions accordingly.

Yes. This is one of Jeyflex’s core strengths — managing PSUR and PBRER submissions across multiple African markets under a single, coordinated programme. Rather than managing separate timelines and separate submissions for each country, Jeyflex consolidates the process and provides a single point of accountability for your entire periodic safety reporting portfolio.

Yes. We have experience helping organisations bring overdue PSUR programmes back into compliance — starting with a rapid assessment of the backlog, prioritising the most urgent submissions by regulatory risk, and working through a structured remediation plan. Contact us to discuss your situation and we will provide a clear plan for getting your PSUR programme back on track.

Never Miss a PSUR Deadline Again

Whether you need a single PSUR authored, a full portfolio managed across multiple African markets, or help catching up on overdue submissions, Jeyflex is ready to help. Speak with our team today.